Sanofi breaks ground on new 36,000-sq-m insulin plant in Frankfurt
read at Endpoints ↗Neutral
Sanofi has broken ground on a new insulin manufacturing facility at its Frankfurt site, covering roughly 36,000 square meters.
The plant is part of the company’s expansion in Germany and is expected to increase insulin production capacity, though details on timelines were not provided.
The announcement also noted that Sanofi signed radioisotope supply deals with Northstar and Telix, and referenced further news from Baxter and United Therapeutics.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Sanofi's new German site; radioisotope deals from Northstar and Telix”
read at Endpoints ↗78 words · retrieved 23m ago
comments(0)
5-min edit window · permanent after that